← FDA Drug Approvals (Drugs@FDA)
NAPROXEN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2025-10-03
Drug application
- FDA Application #
ANDA216504- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NAPROXEN
- Generic name
- NAPROXEN
- Active ingredients
- NAPROXEN
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- AUROBINDO PHARMA
- Manufacturer
- Aurobindo Pharma Limited
- First approval
- 2025-10-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown